Efficacy of integrated tele yoga intervention on physiological and psychological variables in asymptomatic COVID-19 positive patients: A Randomized Control Trial

被引:1
作者
Shrimal, Pragya Jain [1 ]
Maharana, Satyapriya [1 ,6 ]
Dave, Anupama [2 ,3 ]
Raghuram, Nagarathna [4 ]
Thulasi, Arun [5 ]
机构
[1] SVYASA Deemed Be Univ, Dept Yoga & Life Sci, Bengaluru, India
[2] MY Hosp, Dept Obs & Gynac, Indore, India
[3] MGM Med Coll, Indore, India
[4] SVYASA, Arogyadhama, Bengaluru, India
[5] SVYASA Deemed Be Univ, Dept Humanities, Bengaluru, India
[6] SVYASA Deemed Be Univ, 19 Eknath Bhavan, Bengaluru 560019, India
关键词
CLINICAL PROFILE; OUTCOMES;
D O I
10.1159/000528832
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: A study was conducted on asymptomatic COVID-19 positive patients admitted in a COVID-19 hospital in Indore, India during first wave of the pandemic. The objective of the study was to assess the efficacy of an integrated tele-yoga intervention as an adjunct to conventional management on physiological, psychological and mindfulness variables.Methods: In a confirmatory randomized control trial, 60 asymptomatic COVID-19 patients in hospital confinement were randomly allocated to experimental and control groups (n=30). The tele-yoga intervention included breathing exercise, pranayama and meditation and delivered over 30 minutes for 7 days to the experimental group while, the control group continued treatment as usual. Assessment of physiological variables & psychological variables was carried out before intervention and on day seven immediately after intervention. Data was analyzed using SPSS (V.16.0). Results: Mann Whitney U test shows that there was a statistically significant difference between groups regarding all variables (p<0.001). The physiological and psychological variables which included Oxygen Saturation (2.07%), Heart Rate (8.21%), Respiratory Rate (10.04%), Systolic Blood Pressure (6.14%), Diastolic Blood Pressure (8.38%), Visual Analog Scale for Stress (62.78 %), Covid-19 Peritraumatic Distress Index (68.44 %), and State Mindful Attention Awareness Scale (72.72 %) showed significant changes in the experimental group compared to control group. Conclusion: The results of this study suggest that integrated tele-yoga might have therapeutic benefits in improving physiological, psychological, and mindfulness variables in asymptomatic COVID- 19 patients.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 50 条
  • [21] Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
    Spinner, Christoph D.
    Gottlieb, Robert L.
    Criner, Gerard J.
    Arribas Lopez, Jose Ramon
    Cattelan, Anna Maria
    Soriano Viladomiu, Alex
    Ogbuagu, Onyema
    Malhotra, Prashant
    Mullane, Kathleen M.
    Castagna, Antonella
    Chai, Louis Yi Ann
    Roestenberg, Meta
    Tsang, Owen Tak Yin
    Bernasconi, Enos
    Le Turnier, Paul
    Chang, Shan-Chwen
    SenGupta, Devi
    Hyland, Robert H.
    Osinusi, Anu O.
    Cao, Huyen
    Blair, Christiana
    Wang, Hongyuan
    Gaggar, Anuj
    Brainard, Diana M.
    McPhail, Mark J.
    Bhagani, Sanjay
    Ahn, Young
    Sanyal, Arun J.
    Huhn, Gregory
    Marty, Francisco M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1048 - 1057
  • [22] Impact of psychological intervention on anxiety, depression, and post-traumatic stress disorder: results from a longitudinal study of hospitalized Covid-19 patients
    Lamiani, Giulia
    Bonazza, Federica
    Battistini, Chiara Luridiana
    Iovine, Salvatore
    Piscopo, Kyrie
    Bai, Francesca
    Vegni, Elena
    RIVISTA DI PSICHIATRIA, 2024, 59 (03) : 100 - 108
  • [23] Chronic obstructive pulmonary disease access and adherence to pulmonary rehabilitation intervention (CAPRI): Protocol for a randomized controlled trial and adaptations during the COVID-19 pandemic
    Bamonti, Patricia M.
    Robinson, Stephanie A.
    Finer, Elizabeth
    Kadri, Reema
    Gagnon, David
    Richardson, Caroline R.
    Moy, Marilyn L.
    CONTEMPORARY CLINICAL TRIALS, 2023, 129
  • [24] Risk factors associated with hospital transfer among mild or asymptomatic COVID-19 patients in isolation facilities in Tokyo: a case-control study
    Naito, Keisuke
    Narita, Tomoyo
    Murata, Yukari
    Morimura, Naoto
    IJID REGIONS, 2022, 2 : 8 - 15
  • [25] Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial
    Labro, Guylaine
    Tubach, Florence
    Belin, Lisa
    Dubost, Jean-Louis
    Osman, David
    Muller, Gregoire
    Quenot, Jean-Pierre
    Da Silva, Daniel
    Zarka, Jonathan
    Turpin, Matthieu
    Mayaux, Julien
    Lamer, Christian
    Doyen, Denis
    Chevrel, Guillaume
    Plantefeve, Gaetan
    Demeret, Sophie
    Piton, Gael
    Manzon, Cyril
    Ochin, Evelina
    Gaillard, Raphael
    Dautzenberg, Bertrand
    Baldacini, Mathieu
    Lebbah, Said
    Miyara, Makoto
    de Chambrun, Marc Pineton
    Amoura, Zahir
    Combes, Alain
    INTENSIVE CARE MEDICINE, 2022, 48 (07) : 876 - 887
  • [26] Impact of surgical mask on performance and cardiorespiratory responses to submaximal exercise in COVID-19 patients near hospital discharge: A randomized crossover trial
    Poncin, William
    Schalkwijk, Adrien
    Vander Straeten, Charlie
    Braem, Frederic
    Latiers, Fabien
    Reychler, Gregory
    CLINICAL REHABILITATION, 2022, 36 (08) : 1032 - 1041
  • [27] Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial
    Pauline Byakika-Kibwika
    Christine Sekaggya-Wiltshire
    Jerome Roy Semakula
    Jane Nakibuuka
    Joseph Musaazi
    James Kayima
    Cornelius Sendagire
    David Meya
    Bruce Kirenga
    Sarah Nanzigu
    Arthur Kwizera
    Fred Nakwagala
    Ivan Kisuule
    Misaki Wayengera
    Henry G. Mwebesa
    Moses R. Kamya
    William Bazeyo
    BMC Infectious Diseases, 21
  • [28] Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial
    Byakika-Kibwika, Pauline
    Sekaggya-Wiltshire, Christine
    Semakula, Jerome Roy
    Nakibuuka, Jane
    Musaazi, Joseph
    Kayima, James
    Sendagire, Cornelius
    Meya, David
    Kirenga, Bruce
    Nanzigu, Sarah
    Kwizera, Arthur
    Nakwagala, Fred
    Kisuule, Ivan
    Wayengera, Misaki
    Mwebesa, Henry G.
    Kamya, Moses R.
    Bazeyo, William
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [29] Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial
    Barros, Camila Miriam Suemi Sato
    Freire, Raissa Soares
    Frota, Elisangela
    Rezende Santos, Anna Gabriela
    Farias, Maria Eduarda Leao
    Rodrigues, Maria Gabriela Almeida
    Silva, Bernardo Maia
    Prado Jeronimo, Christiane Maria
    Netto, Rebeca Linhares Abreu
    Silva Borba, Mayla Gabriela
    Baia-da-Silva, Djane
    Brito-Sousa, Jose Diego
    Xavier, Mariana Simao
    Araujo-Alexandre, Marcia Almeida
    Sampaio, Vanderson Souza
    Melo, Gisely Cardoso
    Areas, Guilherme Tinoco
    Hajjar, Ludhmila Abrahao
    Monteiro, Wuelton Marcelo
    Gomes Naveca, Felipe
    Costa, Fabio Trindade Maranhao
    Val, Fernando Fonseca Almeida
    Lacerda, Marcus Vinicius Guimaraes
    FRONTIERS IN MEDICINE, 2021, 8
  • [30] Boost your health (Refuerza tu Salud): Design of a randomized controlled trial of a community health worker intervention to reduce inequities in COVID-19 and influenza vaccinations
    Meredith, Lisa S.
    Tobin, Jonathan N.
    Cassells, Andrea
    Howell, Khadesia
    Hernandez, Helin G.
    Gidengil, Courtney
    Williamson, Stephanie
    Dong, Lu
    Timmins, George
    Alvarado, Gabriela
    Holder, Tameir
    Lainez, Jacqueline Cortez
    Lin, T. J.
    Lara, Marielena
    CONTEMPORARY CLINICAL TRIALS, 2025, 153